No Cells? No Problem! eXoZymes' Michael Heltzen on the Future of Microbe-Free Biotech
Erum sits down with Michael Heltzen, CEO of eXoZymes, to dive into the transformative world of cell-free biomanufacturing. Michael shares the origin story of ExoZymes—from a student bioengineering dream at UCLA to ringing the NASDAQ bell—and unpacks why scalability, sustainability, and design thinking are central to the next generation of biotech. If you're curious about how biology can be engineered without living cells, what it takes to commercialize breakthrough science, or how new business models in synthetic biology are emerging, this is the episode for you. Get ready to rethink what’s possible when biology breaks free from the cell wall.
Chapters:
00:00:00 – Unlocking a New Era: Rethinking Natural Resources for the Future
00:00:17 – SynBioBeta Afterglow: Late Nights, Big Ideas, and Bio Buzz
00:02:39 – Breaking the Cell Wall: The Power of Cell-Free Biomanufacturing
00:03:33 – Meet Michael Heltzen: The Visionary Behind the Next Bio Revolution
00:09:54 – Inside NCTX: The Molecule That Might Change Everything
00:16:06 – No Scale, No Impact: Tackling SynBio’s Toughest Bottlenecks
00:26:43 – From Supplements to Cures: Bio’s Leap Across Sectors
00:27:19 – AI x Enzymes: Cracking Nature’s Code in Real Time
00:28:06 – Making Biology Predictable: ML Meets Molecular Design
00:30:14 – Faster Than Nature: How AI Shrinks Production Timelines
00:33:29 – Go-to-Market Moves: Biotech Strategy for the Real World
00:36:07 – Bio Click™: Targeted Enzymes with Industrial Precision
00:38:38 – Life After the Bell: IPOs, Growth, and Big Bio Energy00:42:29 – Zooming Out: Big-Picture Thinking for What Comes Next
